The dearth of a standardized components is partially what makes it hard to identify the overall safety of working with cannabis-derived goods. Because THC and CBD concentration can differ so broadly in product to products, it can make it challenging to conduct reproducible trials over the efficiency of the drug because it's tough to get a reliable